danielnesbitt | 6 months ago | on: Podman Desktop celebrates 3M downloads
danielnesbitt's comments
danielnesbitt | 3 years ago | on: Docker is deleting Open Source organisations - what you need to know
danielnesbitt | 6 years ago | on: Google’s Chrome Becomes Web ‘Gatekeeper’ and Rivals Complain
It seems Microsoft is bit more egregious in Bing. If you search for Chrome or Firefox you get "Promoted by Microsoft - Microsoft Edge is the recommended browser for Windows 10 and it’s already installed on your PC."
danielnesbitt | 7 years ago | on: The FDA is powerless to stop right-to-try profiteers
The rule prevents negative outcomes for risky non-qualified patients from harming the trial, but the converse is also true. Positive outcomes for patients outside the regulated trial will not help gain approval at Phase II or Phase III.
On a board like hn, there's a tendency to look at all data as useful data, but this isn't true in the case of a clinical trial.
On further thinking, I'm not even sure what happens in the case of a patient receiving a pre-approval drug outside of the trial. Handling their data would likely need to meet the same standards required in trial (consent tracking, electronic signatures, etc) without any of the machinery of the trial to help. It could well be the case that nothing is collected if the cost to keep it and use it are too high.
danielnesbitt | 9 years ago | on: Comparing Elixir and Go
For instance, prepending to a linked list results in a new head node, but nothing is actually copied. Appending requires a full copy. A developer has to be aware of where the limitations of these data structures are, but I think that's true of using any library in any language.
danielnesbitt | 9 years ago | on: PurpleJS – A JavaScript application framework running on the JVM
I guess it hit some roadblocks.
https://blogs.oracle.com/theaquarium/entry/project_avatar_up...